1. 79 Re-audit of cisplatin (>70 mg/m2) induced nausea and vomiting, following the introduction of aprepitant. (January 2016) Authors: Mack, E.; Campbell, L.; Scullin, P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Use of the Cutaneous Lupus Disease Area and Severity Index as an outcome measure in clinical trials: a descriptive study. (1st January 2021) Authors: Mack, E.; Exton, L.S.; Mohd Mustapa, M.F.; McCourt, C.; O'Kane, D. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 1(2021) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Use of the Cutaneous Lupus Disease Area and Severity Index as an outcome measure in clinical trials: a descriptive study. (1st October 2020) Authors: Mack, E.; Exton, L.S.; Mohd Mustapa, M.F.; McCourt, C.; O'Kane, D. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 1(2021) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗